Federal Appeals Court Hears AAM's Challenge Of Maryland Price Gouging Law

Attorneys for the generic drug industry and Maryland jostled over the scope of the state's first-in-the-nation generic drug price gouging law during oral arguments Wednesday (Jan. 24) in their ongoing legal battle over the law. The arguments before the Federal Court of Appeals for the Fourth Circuit focused mostly on the Association for Accessible Medicines' view that the law violates the dormant Commerce Clause because it regulates sales between generic companies and wholesalers that occur outside of Maryland. While the...